MARY STOLL: Open Payments
NPI 1083862098 · PETOSKEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$871 in 47 payments from 11 companies in 2025. Trend: 2023 $541 · 2024 $681 · 2025 $871
Food & beverage: $743Education: $128
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $286 |
| Novartis Pharmaceuticals Corporation | 17 | $202 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| E.R. Squibb & Sons, L.L.C. | 2 | $64 |
| Janssen Biotech, Inc. | 3 | $58 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $53 |
| Galderma Laboratories, L.P. | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| UCB, Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: SKYRIZI, COSENTYX, DUPIXENT, RINVOQ, Sotyktu, TREMFYA, ILUMYA, NEMLUVIO.
Industry payments across MI — which companies pay providers there.
